During continuous veno‑venous hemofiltration (CVVHF) with citrate anticoagulation, how should calcium be administered and managed using an infusion pump?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Calcium Management During CVVHF with Citrate Anticoagulation

During CVVHF with citrate anticoagulation, administer calcium replacement via infusion pump using continuous IV infusion at rates calculated based on extracorporeal calcium loss, with frequent monitoring of both post-filter ionized calcium (target 0.3-0.4 mmol/L) and systemic ionized calcium (target normal range), measuring levels every 1-4 hours during continuous infusion 1, 2.

Administration Protocol

Dilution and Infusion Setup

  • Dilute calcium gluconate (100 mg/mL) in 5% dextrose or normal saline to a concentration of 5.8-10 mg/mL for continuous infusion 2
  • Use a dedicated secure IV line to prevent calcinosis cutis and tissue necrosis 2
  • Never mix calcium with fluids containing bicarbonate or phosphate as precipitation will occur 1

Calculating Calcium Replacement Rates

The calcium infusion rate must account for two primary losses:

  1. Extracorporeal calcium removal through the CVVH circuit
  2. Citrate-calcium complex formation in the systemic circulation

Use this practical equation for calcium supplementation 3:

  • Calcium infusion rate (mmol/h) = 1.77 + 0.8 × (calcium loss rate by CVVH, mmol/h)

To estimate calcium loss by CVVH 4:

  • Calcium excretion (mmol/24h) = -1.29 + 0.646 × [total blood calcium] × ultrafiltrate (L/24h) + 0.107 × blood flow (mL/h)

Two-Phase Calcium Supplementation Approach

Phase 1 (Initial period until citrate steady state):

  • Higher calcium infusion rates needed to compensate for both circuit losses and increasing citrate-calcium complexes 5
  • Typical starting rate: 5.5 mmol/h (approximately 500 mg/h of calcium gluconate) 3

Phase 2 (After citrate steady state achieved, typically 4-6 hours):

  • Reduce calcium infusion rate as systemic citrate stabilizes 5
  • Adjust based on measured calcium losses rather than citrate infusion rate 3

Monitoring Requirements

Frequency

  • Every 1-4 hours during continuous infusion 1, 2
  • More frequent monitoring (every 1-2 hours) during initial setup and dose adjustments

Parameters to Monitor

Post-filter ionized calcium:

  • Target: 0.3-0.4 mmol/L 6
  • Alternatively, monitor post-filter ACT with target 200-250 seconds 6
  • This guides citrate dosing, not calcium replacement

Systemic ionized calcium:

  • Target: Normal range (1.0-1.3 mmol/L) 1
  • This directly guides calcium replacement rate
  • Critical threshold: Do not allow to drop below 0.9 mmol/L 7

Total-to-ionized calcium ratio:

  • Monitor to detect citrate accumulation 8
  • Rising ratio suggests inadequate citrate metabolism

Acid-base status:

  • Check regularly in patients at high risk for citrate accumulation (liver failure, shock) 1

Critical Pitfalls to Avoid

Do Not Base Calcium Replacement Solely on Ionized Calcium Levels

Most patients develop negative calcium balance despite normal plasma ionized calcium 4. In one study, mean cumulative calcium balance ranged from -3687 to +448 mmol, with mean daily balance of -12 mmol/24h despite "adequate" supplementation. This occurs because:

  • Skeletal calcium mobilization masks true calcium depletion
  • Standard monitoring misses total body calcium losses
  • Long-term demineralization risk is substantial

Infusion Rate Limits

  • Maximum bolus rate: 200 mg/min in adults, 100 mg/min in pediatrics 2
  • For continuous infusion, no absolute maximum but titrate carefully with ECG monitoring
  • Rapid administration causes hypotension, bradycardia, and arrhythmias 2

Drug Incompatibilities

  • Absolutely contraindicated: Do not mix with ceftriaxone - forms fatal precipitates, especially in neonates 2
  • Avoid mixing with bicarbonate, phosphate, or minocycline 2

Cardiac Glycoside Interaction

If patient is on digoxin or other cardiac glycosides, administer calcium very slowly with continuous ECG monitoring as synergistic arrhythmias can occur 2

Practical Algorithm

  1. Start calcium gluconate infusion at 5.5 mmol/h (500 mg/h)
  2. Measure systemic and post-filter ionized calcium at 1 hour
  3. Adjust calcium rate based on systemic ionized calcium:
    • If <1.0 mmol/L: increase by 1-2 mmol/h
    • If 1.0-1.3 mmol/L: maintain current rate
    • If >1.35 mmol/L: decrease by 1-2 mmol/h
  4. Recheck every 1-2 hours initially, then every 2-4 hours once stable
  5. After 4-6 hours, reassess and likely reduce rate as citrate reaches steady state
  6. Calculate actual calcium losses using the equations above and adjust to match losses plus 1.77 mmol/h baseline

Special Populations

Renal impairment: Start at lowest recommended dose with calcium checks every 4 hours 2

High ultrafiltration rates: Expect proportionally higher calcium losses requiring increased replacement 4, 9

This approach prevents both hypocalcemia-related complications and long-term skeletal demineralization while avoiding hypercalcemia and its associated risks.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.